EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Taro Pharmaceutical Industries's enterprise value is $734.7 Mil.
Taro Pharmaceutical Industries's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $610.8 Mil. Therefore, Taro Pharmaceutical Industries's EV-to-Revenue for today is 1.20.
The historical rank and industry rank for Taro Pharmaceutical Industries's EV-to-Revenue or its related term are showing as below:
TARO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.11 Med: 3.51 Max: 8.53
Current: 1.2
During the past 13 years, the highest EV-to-Revenue of Taro Pharmaceutical Industries was 8.53. The lowest was 0.11. And the median was 3.51.
TARO's EV-to-Revenue is ranked better than 73.78% of 1026
companies
in the Drug Manufacturers industry
Industry Median: 2.315
vs TARO: 1.20
As of today (2024-04-16), Taro Pharmaceutical Industries's stock price is $42.05.
Taro Pharmaceutical Industries's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $16.25. Therefore, Taro Pharmaceutical Industries's PS Ratio for today is 2.59.
Taro Pharmaceutical Industries EV-to-Revenue Historical Data
The historical data trend for Taro Pharmaceutical Industries's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Taro Pharmaceutical Industries Annual Data
Trend
Mar14
Mar15
Mar16
Mar17
Mar18
Mar19
Mar20
Mar21
Mar22
Mar23
EV-to-Revenue
4.66
1.92
3.22
1.44
0.11
Taro Pharmaceutical Industries Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
1.92
0.11
1.08
0.86
1.09
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taro Pharmaceutical Industries EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Taro Pharmaceutical Industries's EV-to-Revenue falls into.
Taro Pharmaceutical Industries's current Enterprise Value is $734.7 Mil.
Taro Pharmaceutical Industries's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $610.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taro Pharmaceutical Industries's share price for today is $42.05.
Taro Pharmaceutical Industries's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taro Pharmaceutical Industries EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TARO has been successfully added to your 